Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer-Reference-Cited by-同舟云学术

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer

Published:2003-03 Issue:6 Volume:88 Page:814-821
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Schellens J H M,Planting A S Th,van Zandwijk N,Ma J,Maliepaard M,van der Burg M E L,de Boer-Dennert M,Brouwer E,van der Gaast A,van den Bent M J,Verweij J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6600794.pdf

Reference41 articles.

1. Bajorin DF, Sarosdy MF, Pfister DG, Mazumdar M, Motzer RJ, Scher HI, Geller NL, Fair WR, Herr H, Sogani P (1993) Randomized trail of etoposie and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multinstitutional study. J Clin Oncol 11: 593–595

2. Common Toxicity Criteria (1998) Cancer Therapy Evaluation Program, Division of Cancer Treatment. National Cancer Institute, Bethesda MD, USA

3. Eastman A, Schulte N (1988) Enhanced DNA repair as a mechanism of resistance to cis-diaminedichloroplatinum (II). Biochemistry 27: 4730–4734

4. Font A, Moyano AJ, Puerto JM, Tres A, Garcia-Giron C, Barneto I, Anton A, Sanchez JJ, Salvador A, Rosell R (1999) Increasing dose intensity of cisplatin–etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group. Cancer 85: 855–863

5. Fukuoka M, Negoro S, Masuda N, Kusoni Y, Matsui K, Ryu S, Takifuji N, Kudoh S, Takada M, (1992) Mitomycin C vindesine and cisplatin in advanced non-small cell lung cancer: a phase II study. Am J Clin Oncol 15: 18–22

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Better survival in impaired renal function patients with metastatic non-small cell lung cancer treated by cisplatin-pemetrexed;European Journal of Clinical Pharmacology;2020-06-21

2. Aqueous extract of Cordyceps sinensis potentiates the antitumor effect of DDP and attenuates therapy-associated toxicity in non-small cell lung cancer via IκBα/NFκB and AKT/MMP2/MMP9 pathways;RSC Advances;2017

3. Cisplatin dose adjustment in patients with renal impairment, which recommendations should we follow?;International Journal of Clinical Pharmacy;2014-01-17

4. Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer;Bioanalysis;2013-02

5. Associations Between ABCC2 Polymorphisms and Cisplatin Disposition and Efficacy;Clinical Pharmacology & Therapeutics;2012-04-25